Illumina on Monday announced that it has publicly filed a Form 10 registration statement with the U.S. Securities and Exchange Commission, in connection with its intended divestiture of GRAIL. A version of this registration statement was submitted to the SEC last December as required. The Form 10 includes detailed information about GRAIL, including historic financial information, a description of GRAIL’s business and strategy, and other legal and financial disclosures. This filing is a necessary step for a capital markets transaction; however, it is not an indication of the means by which Illumina will ultimately divest GRAIL. “Illumina remains committed to divesting GRAIL expeditiously, and on terms consistent with our divestment plan, which was approved by the European Commission. Our goal is to finalize the divestiture terms by the end of the second quarter of 2024,” said Jacob Thaysen, CEO of Illumina. “Illumina’s Board and management team continue to focus on our core business, supporting our customers, and driving long-term growth.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target lowered to $176 from $185 at Scotiabank
- Evercore ISI removes several healthcare names from ‘Tactical Outperform’ list
- Illumina price target lowered to $195 from $200 at Evercore ISI
- Illumina price target lowered to $140 from $151 at TD Cowen
- Illumina price target raised to $128 from $125 at Baird